Up Front Antibody-Drug Conjugates: Shifting the Paradigm in Metastatic Triple-Negative Breast Cancer Treatment

Did you know that antibody-drug conjugates (ADCs) targeting Trop2 have demonstrated significant clinical potential for patients with TNBC? Credit available for this activity expires: 4/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/front-antibody-drug-conjugates-shifting-paradigm-metastatic-2026a1000a9z?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Apr 9, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Up Front Antibody-Drug Conjugates: Shifting the Paradigm in Metastatic Triple-Negative Breast Cancer Treatment

0:00 38:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 38 minutes long.

When was this Keeping Current CME episode published?

This episode was published on April 9, 2026.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!